Novartis halts distribution of its Zantac versions amid probe into impurities


Novartis AG’s Sandoz unit said on Wednesday it was halting distribution of its versions of the drug commonly known as Zantac in all its markets, including the United States and Canada, after contaminants were found in the heartburn drug.

Read on Reuters